Akums Launches Drug for Gastrointestinal Disorders - DCGI Approval
By Rediff Money Desk, New Delhi Jun 10, 2024 14:17
Akums Drugs & Pharmaceuticals launches a new combination drug for gastrointestinal tract disorders, Rabeprazole and Levosulpiride SR capsules, following DCGI approval.
New Delhi, Jun 10 (PTI) Akums Drugs & Pharmaceuticals on Monday said it has launched a combination drug for gastrointestinal tract disorders.
The contract development and manufacturing organisation has launched Rabeprazole and Levosulpiride SR capsules after getting approval from the Drug Controller General of India (DCGI), it said in a statement.
Akums Drugs & Pharmaceuticals Joint Managing Director Sanjeev Jain said the medication offers an effective remedy by easing symptoms, enhancing gastrointestinal function, and boosting patients' overall well-being.
"Clinical studies have demonstrated that Rabeprazole not only alleviates heartburn but also improves other dyspepsia-related symptoms. Levosulpiride offers rapid relief and better healing outcomes with fewer side effects, elevating the overall treatment experience," he added.
The company said the combination drug is a first-of-its-kind solution.
GERD, or gastro-oesophageal reflux disease is characterised by the reflux of stomach contents into the oesophagus, leading to troublesome symptoms and potential complications.
The contract development and manufacturing organisation has launched Rabeprazole and Levosulpiride SR capsules after getting approval from the Drug Controller General of India (DCGI), it said in a statement.
Akums Drugs & Pharmaceuticals Joint Managing Director Sanjeev Jain said the medication offers an effective remedy by easing symptoms, enhancing gastrointestinal function, and boosting patients' overall well-being.
"Clinical studies have demonstrated that Rabeprazole not only alleviates heartburn but also improves other dyspepsia-related symptoms. Levosulpiride offers rapid relief and better healing outcomes with fewer side effects, elevating the overall treatment experience," he added.
The company said the combination drug is a first-of-its-kind solution.
GERD, or gastro-oesophageal reflux disease is characterised by the reflux of stomach contents into the oesophagus, leading to troublesome symptoms and potential complications.
Source: PTI
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- ARC Finance
- 1.51 (+ 2.72)
- 99106131
- Vodafone Idea L
- 8.27 (+ 1.72)
- 37910491
- Guj. Toolroom Lt
- 18.98 (+ 4.98)
- 33052379
- Srestha Finvest
- 0.81 ( -2.41)
- 24087791
- Filatex Fashions
- 0.69 ( -4.17)
- 20455844
MORE NEWS
Adani Wilmar to Emulate ITC, Expand FMCG Portfolio
Adani Wilmar, India's largest edible oil company, plans to leverage its core business...
India to Boost Exports: 20 Nations Meet Jan 6-8
Indian officials from 20 countries will meet in New Delhi to discuss strategies to...
Karur Vysya Bank Expands in Tamil Nadu with Two...
Karur Vysya Bank has opened two new branches in Tamil Nadu, bringing its total branch...